Latest News
Therapix Biosciences Drug Candidate THX-160 Demonstrates Efficacy in Treatment of Pain
20 July 2018 - - Tel Aviv, Israel-based cannabinoid-based treatments developer Therapix Biosciences Ltd. (NASDAQ: TRPX) has released positive results in its pre-clinical studies evaluating THX-160, a novel pharmaceutical CB2 Receptor agonist for the ...
SOM Biotech Commences Phase 2a Clinical Trial of SOM3355 in Huntington's Disease
...
Craig Thompson Named President, CEO of Neurana Pharmaceuticals
20 July 2018 - - San Diego, California-based specialty pharmaceutical company Neurana Pharmaceuticals, Inc. has appointed Craig Thompson as president and CEO, and has appointed Toni Foster as senior vice president of Medical Operations and Program Ma...
US FDA Grants IND Clearance to RDD Pharma for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients
20 July 2018 - - The US Food and Drug Administration has cleared New York, New York-based specialty pharmaceutical company RDD Pharma's investigational new drug (IND) application which permits the initiation of the clinical development program f...
AbbVie Grants Non-exclusive License for Humira (adalimumab) to Mylan
20 July 2018 - - North Chicago, Illinois-based global biopharmaceutical company AbbVie (NYSE: ABBV) has inked patent license agreements with Mylan over its proposed biosimilar adalimumab product, the company said.
Under the terms of the agree...